인쇄하기
취소
|
The Ministry of Health and Welfare(MOHW) clearly expressed its stance that gene and cell therapies cannot be an exception on economic evaluation when getting evaluated for the health insurance benefits.
Senior Manager Myung-Seob Kwak at the Insurance Policy Division announced this at debate about the pharmaceutical field(Patient-Oriented High-Tech Research Trend) at the ‘2017 AMCHAM Healthcare...